Teleflex Incorporated (NYSE:TFX) Shares Acquired by Aigen Investment Management LP

Aigen Investment Management LP boosted its holdings in Teleflex Incorporated (NYSE:TFX) by 33.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,883 shares of the medical technology company’s stock after purchasing an additional 718 shares during the quarter. Aigen Investment Management LP’s holdings in Teleflex were worth $713,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Cromwell Holdings LLC lifted its position in shares of Teleflex by 59.0% during the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after buying an additional 49 shares during the last quarter. Ashton Thomas Securities LLC purchased a new stake in Teleflex in the third quarter valued at $40,000. GAMMA Investing LLC lifted its position in Teleflex by 131.1% in the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock valued at $42,000 after acquiring an additional 97 shares during the last quarter. Canada Pension Plan Investment Board purchased a new position in shares of Teleflex during the second quarter worth about $42,000. Finally, Versant Capital Management Inc increased its position in shares of Teleflex by 20,700.0% during the second quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock worth $44,000 after purchasing an additional 207 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently issued reports on TFX. Stephens upped their target price on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Tuesday. Royal Bank of Canada cut their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Truist Financial reiterated a “hold” rating and set a $227.00 price target (down previously from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Friday, November 1st. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $259.25.

Insiders Place Their Bets

In other news, Director Stuart A. Randle sold 2,674 shares of the company’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total transaction of $638,898.82. Following the transaction, the director now directly owns 5,496 shares of the company’s stock, valued at $1,313,159.28. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.43% of the stock is currently owned by company insiders.

Teleflex Stock Down 0.8 %

Shares of Teleflex stock opened at $193.98 on Thursday. The company has a market cap of $9.01 billion, a P/E ratio of 38.56, a PEG ratio of 2.00 and a beta of 1.18. The firm has a fifty day moving average of $233.46 and a two-hundred day moving average of $223.73. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a one year low of $193.49 and a one year high of $257.85.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same quarter last year, the firm earned $3.64 earnings per share. The firm’s revenue was up 2.4% compared to the same quarter last year. On average, analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date is Friday, November 15th. Teleflex’s dividend payout ratio is presently 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.